These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37891632)

  • 61. How do naloxone-based interventions work to reduce overdose deaths: a realist review.
    Miller NM; Waterhouse-Bradley B; Campbell C; Shorter GW
    Harm Reduct J; 2022 Feb; 19(1):18. PubMed ID: 35197057
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
    Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
    Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Law enforcement attitudes towards naloxone following opioid overdose training.
    Purviance D; Ray B; Tracy A; Southard E
    Subst Abus; 2017; 38(2):177-182. PubMed ID: 27715714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
    Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
    BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regional and temporal effects of naloxone access laws on opioid overdose mortality.
    Cataife G; Dong J; Davis CS
    Subst Abus; 2021; 42(3):329-338. PubMed ID: 31951788
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
    Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
    J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Naloxone for Opioid Overdose: Comment.
    Milas BL; Varon AJ
    Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
    [No Abstract]   [Full Text] [Related]  

  • 70. Naloxone for Opioid Overdose: Comment.
    Pattullo GG
    Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
    [No Abstract]   [Full Text] [Related]  

  • 71. Barriers to calling emergency services amongst people who use substances in the event of overdose: A scoping review.
    Byles H; Sedaghat N; Rider N; Rioux W; Loverock A; Seo B; Dhanoa A; Orr T; Dunnewold N; Tjosvold L; Ghosh SM
    Int J Drug Policy; 2024 Oct; 132():104559. PubMed ID: 39197374
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population.
    Bascou NA; Haslund-Gourley B; Amber-Monta K; Samson K; Goss N; Meredith D; Friedman A; Needleman A; Kumar VK; Fischer BD
    Harm Reduct J; 2022 Jan; 19(1):5. PubMed ID: 35034649
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?
    Koester S; Mueller SR; Raville L; Langegger S; Binswanger IA
    Int J Drug Policy; 2017 Oct; 48():115-124. PubMed ID: 28734745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harms.
    Leece P; Khorasheh T; Paul N; Keller-Olaman S; Massarella S; Caldwell J; Parkinson M; Strike C; Taha S; Penney G; Henderson R; Manson H
    BMJ Open; 2019 Sep; 9(9):e028583. PubMed ID: 31515417
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.
    Khan MR; Hoff L; Elliott L; Scheidell JD; Pamplin JR; Townsend TN; Irvine NM; Bennett AS
    Harm Reduct J; 2023 Feb; 20(1):24. PubMed ID: 36841763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of provider attitudes toward #naloxone on Twitter.
    Haug NA; Bielenberg J; Linder SH; Lembke A
    Subst Abus; 2016; 37(1):35-41. PubMed ID: 26860229
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.
    Tabatabai M; Cooper RL; Wilus DM; Edgerton RD; Ramesh A; MacMaster SA; Patel PN; Singh KP
    J Prim Care Community Health; 2023; 14():21501319221147246. PubMed ID: 36625264
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Trends in overdose experiences and prevention behaviors among people who use opioids in Baltimore, MD, 2017-2019.
    Dayton L; Mazhnaya A; Schneider KE; Kong X; Winiker A; Davey-Rothwell M; Tobin KE; Latkin CA
    Drug Alcohol Depend; 2021 Apr; 221():108650. PubMed ID: 33684772
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overdose Awareness and Reversal Trainings at Philadelphia Public Libraries.
    Lowenstein M; Feuerstein-Simon R; Dupuis R; Herens A; Hom J; Sharma M; Sheni R; Encarnacion L; Flaherty C; Cueller M; Cannuscio C
    Am J Health Promot; 2021 Feb; 35(2):250-254. PubMed ID: 32662281
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
    Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.